Literature DB >> 12793774

Differential diagnosis of neurologically expressed disorders in Western European cattle.

C Saegerman1, L Claes, A Dewaele, D Desmecht, F Rollin, J Hamoir, P Gustin, G Czaplicki, J Bughin, J Wullepit, J Laureyns, S Roels, D Berkvens, E Vanopdenbosch, E Thiry.   

Abstract

A classification of neurological or neurologically expressed disorders that occur in Western European cattle aged 12 month and over has been established on the basis of aetiology, frequency and conditions of appearance, age and type of animals concerned and the main clinical signs observed. Neurologically expressed disorders have been classified according to different groups of causes: biological, non-biological and non-specific or unknown. Differential diagnosis of neurologically expressed disorders is an essential element in the clinical epidemiological surveillance of bovine spongiform encephalopathy. A growing number of aetiologies are described in the scientific literature. The identification and centralised management of neurological disorders will make it possible, one the one hand, to take account of the inherent variability in the clinical forms encountered and in the diagnostic approaches of the observers and, on the other hand, to identify new risk factors in order to control them.

Entities:  

Mesh:

Year:  2003        PMID: 12793774

Source DB:  PubMed          Journal:  Rev Sci Tech        ISSN: 0253-1933            Impact factor:   1.181


  2 in total

1.  Population-level retrospective study of neurologically expressed disorders in ruminants before the onset of bovine spongiform encephalopathy (BSE) in Belgium, a BSE risk III country.

Authors:  C Saegerman; D Berkvens; L Claes; A Dewaele; F Coignoul; R Ducatelle; D Cassart; B Brochier; F Costy; S Roels; H Deluyker; E Vanopdenbosch; E Thiry
Journal:  J Clin Microbiol       Date:  2005-02       Impact factor: 5.948

2.  Decision support tools for clinical diagnosis of disease in cows with suspected bovine spongiform encephalopathy.

Authors:  C Saegerman; N Speybroeck; S Roels; E Vanopdenbosch; E Thiry; D Berkvens
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.